227 related articles for article (PubMed ID: 12004863)
21. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain.
Madrigal JL; Olivenza R; Moro MA; Lizasoain I; Lorenzo P; Rodrigo J; Leza JC
Neuropsychopharmacology; 2001 Apr; 24(4):420-9. PubMed ID: 11182537
[TBL] [Abstract][Full Text] [Related]
22. Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain.
Gellerich FN; Trumbeckaite S; Hertel K; Zierz S; Müller-Werdan U; Werdan K; Redl H; Schlag G
Shock; 1999 May; 11(5):336-41. PubMed ID: 10353539
[TBL] [Abstract][Full Text] [Related]
23. Interaction between succinate dehydrogenase and ubiquinone-binding protein from succinate-ubiquinone reductase.
Yu L; Yu CA
Biochim Biophys Acta; 1980 Nov; 593(1):24-38. PubMed ID: 7426645
[No Abstract] [Full Text] [Related]
24. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria.
Birch-Machin MA; Briggs HL; Saborido AA; Bindoff LA; Turnbull DM
Biochem Med Metab Biol; 1994 Feb; 51(1):35-42. PubMed ID: 8192914
[TBL] [Abstract][Full Text] [Related]
25. Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse.
Kwong LK; Sohal RS
Arch Biochem Biophys; 2000 Jan; 373(1):16-22. PubMed ID: 10620319
[TBL] [Abstract][Full Text] [Related]
26. Electron-transfer complexes of Ascaris suum muscle mitochondria. II. Succinate-coenzyme Q reductase (complex II) associated with substrate-reducible cytochrome b-558.
Takamiya S; Furushima R; Oya H
Biochim Biophys Acta; 1986 Jan; 848(1):99-107. PubMed ID: 3753651
[TBL] [Abstract][Full Text] [Related]
27. Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase).
Miyadera H; Shiomi K; Ui H; Yamaguchi Y; Masuma R; Tomoda H; Miyoshi H; Osanai A; Kita K; Omura S
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):473-7. PubMed ID: 12515859
[TBL] [Abstract][Full Text] [Related]
28. Toxin-induced mitochondrial dysfunction.
Browne SE; Beal MF
Int Rev Neurobiol; 2002; 53():243-79. PubMed ID: 12512343
[No Abstract] [Full Text] [Related]
29. Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
van de Water B; Zoeteweij JP; de Bont HJ; Nagelkerke JF
Mol Pharmacol; 1995 Nov; 48(5):928-37. PubMed ID: 7476924
[TBL] [Abstract][Full Text] [Related]
30. Studies of the electron transport chain of the euryarcheon Halobacterium salinarum: indications for a type II NADH dehydrogenase and a complex III analog.
Sreeramulu K; Schmidt CL; Schäfer G; Anemüller S
J Bioenerg Biomembr; 1998 Oct; 30(5):443-53. PubMed ID: 9932647
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial ubiquinol oxidation is necessary for tumour growth.
Martínez-Reyes I; Cardona LR; Kong H; Vasan K; McElroy GS; Werner M; Kihshen H; Reczek CR; Weinberg SE; Gao P; Steinert EM; Piseaux R; Budinger GRS; Chandel NS
Nature; 2020 Sep; 585(7824):288-292. PubMed ID: 32641834
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
Menzies FM; Cookson MR; Taylor RW; Turnbull DM; Chrzanowska-Lightowlers ZM; Dong L; Figlewicz DA; Shaw PJ
Brain; 2002 Jul; 125(Pt 7):1522-33. PubMed ID: 12077002
[TBL] [Abstract][Full Text] [Related]
33. Effect of iron deficiency on succinate- and NADH-ubiquinone oxidoreductases in skeletal muscle mitochondria.
Ackrell BA; Maguire JJ; Dallman PR; Kearney EB
J Biol Chem; 1984 Aug; 259(16):10053-9. PubMed ID: 6432778
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH; Cooper JM; Dexter D; Clark JB; Jenner P; Marsden CD
J Neurochem; 1990 Mar; 54(3):823-7. PubMed ID: 2154550
[TBL] [Abstract][Full Text] [Related]
35. [Succinate-ubiquinone reductase site of the respiratory chain].
Vinogradov AD
Biokhimiia; 1986 Dec; 51(12):1944-73. PubMed ID: 3542059
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome.
Fillano JJ; Goldenthal MJ; Rhodes CH; Marín-García J
J Child Neurol; 2002 Jun; 17(6):435-9. PubMed ID: 12174964
[TBL] [Abstract][Full Text] [Related]
37. Studies on the succinate dehydrogenating system. Isolation and properties of the mitochondrial succinate-ubiquinone reductase.
Tushurashvili PR; Gavrikova EV; Ledenev AN; Vinogradov AD
Biochim Biophys Acta; 1985 Sep; 809(2):145-59. PubMed ID: 2994719
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome c-mediated electron transfer between ubiquinol-cytochrome c reductase and cytochrome c oxidase. Kinetic evidence for a mobile cytochrome c pool.
Froud RJ; Ragan CI
Biochem J; 1984 Jan; 217(2):551-60. PubMed ID: 6320810
[TBL] [Abstract][Full Text] [Related]
40. The impact of diabetes on CNS. Role of bioenergetic defects.
Kaur G; Bhardwaj SK
Mol Chem Neuropathol; 1998; 35(1-3):119-31. PubMed ID: 10343974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
